We reported earlier that RUNX3 is expressed in human and mouse gastrointestinal tract (GIT) epithelium and that it functions as a tumor suppressor in gastric and colorectal tissues. However, there have been conflicting reports describing the absence of Runx3 in GIT epithelial cells. A part of the controversy may be derived from the use of a specific antibody by other groups (referred to as G-poly). Here, we show further evidence to support our earlier observations and provide a possible explanation for this apparent controversy. We generated multiple anti-RUNX3 monoclonal antibodies and found that RUNX3 antibodies recognizing the RUNX3 N-terminal region (residues 1-234) react with RUNX3 in gastric epithelial cells, whereas those recognizing the C-terminal region (beyond residue 234) did not. G-poly primarily recognizes the region beyond 234 and hence, is unable to detect Runx3 in this tissue.
RUNX genes have attracted great deal of attention due to their critical roles during development and contributions to oncogenesis (Ito, 2008) . In the case of Runx3, it mediates epigenetic silencing of CD4 gene during the establishment of cytotoxic CD8 T lymphocytes (Taniuchi et al., 2002; Woolf et al., 2003) . In dorsal root ganglion (DRG) neurons, both Runx3 and Runx1 play critical roles in lineage commitment of sensory subtypes and axon pathfinding (Inoue et al., , 2007 Levanon et al., 2002; Chen et al., 2006a, b; Kramer et al., 2006; Marmige`re et al., 2006) . Runx3 is expressed in large diameter DRG neurons that express neurotrophin receptor TrkC (Levanon et al., 2002; Chen et al., 2006b; Kramer et al., 2006; Nakamura et al., 2008) .
We reported earlier that Runx3 is expressed by mouse gastrointestinal tract (GIT) epithelial cells and constitutes an important tumor suppressor in gastric and colon cancers. RUNX3 was found to be inactivated not only by epigenetic silencing but also by protein mislocalization at the cytoplasm, resulting in dysfunction of RUNX3 in high proportion of gastric and colon cancer cases (Li et al., 2002; Ito et al., 2005 Ito et al., , 2008 . A mutation of Arg122 to Cys in the conserved Runt domain abolished the tumor-suppressive effect of RUNX3 (Li et al., 2002) . Several other groups have also demonstrated the expression of RUNX3 mRNA and/or protein in gastric epithelial cells (Osaki et al., 2004; Oshimo et al., 2004; Torquati et al., 2004; Wei et al., 2005; Zavros et al., 2005; Katuri et al., 2006; Peng et al., 2006; Usui et al., 2006) . However, others have failed to demonstrate the expression of Runx3 in normal gastric epithelial cells immunohistochemically using G-poly and this has led them to question its contribution to carcinogenesis in GIT epithelium (Levanon et al., 2001 (Levanon et al., , 2003 Brenner et al., 2004 , Carvalho et al., 2005 . Here, we resolve the controversy by identifying the unusual properties of the anti-RUNX3 antibodies used for these studies and we report the production of a series of monoclonal antibodies that can clearly identify Runx3 in epithelial cells of the GIT (Yano et al., 2006; Ito et al., 2008) .
Epithelial cells were isolated from mouse stomach, small and large intestines by previously described methods (Figure 1b ; Li et al., 2002) . Quantitative RT-PCR analysis on the RNA obtained from this purified epithelium detected two species of Runx3 mRNAs that are transcribed from the proximal and distal promoters and encode full-length Runx3 proteins, p44 and p46, respectively ( Figures 1a, d and e). Correspondingly, western blot analysis of the extract from this purified epithelium showed the presence of both species of fulllength Runx3, p44 and p46 (Figure 1c , see below for antibody specifications). Depending on the tissue, the Runx3 RNA levels in the GIT tissues ranged from 20 to 75% of levels in peripheral blood cells that express all three Runx genes (Figures 1d and e) . In another quantitative RT-PCR assay with these GIT epithelial cells, we utilized the Runx3-specific TaqMan probe (Mm00490666_m1) that detects most of Runx3 RNA splice variants. This analysis revealed that the Runx3 mRNA is expressed by GIT epithelial cells at about 10% of the levels in blood cells (data not shown). As for the other Runx genes, Runx1 is clearly expressed by GIT epithelium as observed by others (Levanon et al., 2001; Brenner et al., 2004) . Very low levels of Runx2 expression were detected (data not shown).
To address why G-poly was unable to detect Runx3 in mouse GIT epithelial cells, we generated multiple anti-RUNX3/Runx3 monoclonal antibodies and compared their abilities to that of G-poly (a kind gift from Yoram Groner). First, we determined the specificities of all these antibodies by western blotting. The pan-reactive monoclonal antibody Rp-3D9 reacted with all three RUNX/Runx proteins of both humans and mouse origins. Four anti-RUNX3 monoclonal antibodies, R3-1E10, R3-3F12, R3-10C7 and R3-8C9, reacted only with RUNX3/Runx3. G-poly reacted with RUNX3/Runx3 most strongly but also cross-reacted significantly with RUNX1/Runx1 and RUNX2/Runx2 ( Figure 2a ). We then used a series of RUNX3 deletion constructs to map the regions of RUNX3 recognized by these antibodies (Figures 2b and c) . The western blot results are summarized in Figure 2d . G-poly was raised against the C-terminal 270 amino acids of RUNX3 (Le et al., 1999) . Accordingly, the results in Figure 2c indicate that G-poly strongly recognizes a region of RUNX3 between residues 235 and 283 that was also recognized by R3-10C7 (Figures 2c and d) . While G-poly should, theoretically, recognize the amino-acid region spanning 284 and 415, we did not assess the strength of its interaction with subregions within this portion of RUNX3. The faint band (marked by an arrowhead) in lane 1-234 in Figure 2c is likely to represent the protein product of deletion construct 1-234. Therefore, G-poly may react with the region 188-234 very weakly.
We tested these antibodies for their ability to detect Runx3 in DRG neurons from wild-type mice (Figure 3a) . The negative control used was DRG from age-matched Runx3 À/À mice. With the exception of R3-1E10, all anti-RUNX3 monoclonal antibodies in this study reacted to the wild-type DRG neurons (see below). G-poly reacted most strongly with DRG neurons. Likewise, R3-10C7 reacted positively with DRG neurons (Figure 3a) .
The Runx3 þ /À mice that we generated express a chimeric protein comprising the N-terminal region of Runx3 fused to bacterial b-galactosidase (Li et al., 2002) . The expression pattern of this chimeric protein should faithfully mimic the expression pattern of endogenous Runx3. As shown in Figure 3b , bacterial b-galactosidase was detected in gastric epithelial cells of Runx3 þ /À mouse, with high expression at surface epithelial cells and the bottom of the gland where chief cells reside. This expression pattern is reminiscent of those previously shown for human and mouse gastric epithelium by in situ hybridization as well as immunohistochemistry using anti-RUNX3 monoclonal antibody (Li et al., 2002; Ito et al., 2005) .
We then assessed the suitability of our monoclonal antibodies for immunohistochemical analysis of gastric À/À gastric epithelial cells as revealed by western blotting using 0.2 mg/ml of R3-1E10, R3-3F12, and R3-10C7 (see Figure 2) . The anti-b-actin antibody (Sigma; A5441) served as the protein loading control. Lysates (40 mg per lane) were prepared from purified WT and Runx3 À/À gastric epithelial cells. (d, e) Relative p44 (d) and p46 (e) Runx3 mRNA expression in peripheral blood cells (B) and epithelial cells isolated from the murine stomach (S), jejunum (J) and large intestine (L). RNA was purified using an RNeasy Kit (Qiagen) and the first strand cDNA obtained by an Omniscript RT Kit (Qiagen). Quantitative PCR analysis was performed using a SYBR Green PCR Kit (Qiagen) with primer sets as shown in (a) on the 7500 Fast Real-Time PCR System (Applied Biosystems). The values were normalized to that of b-actin mRNA obtained by TaqMan Gene Expression Assays (Applied Biosystems; Mm00607939_s1).
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tissues from wild-type adult mice. As shown in Figure 3c , R3-1E10 and R3-3F12 reacted with Runx3 in epithelial cells. None of the monoclonal antibodies showed reactivity to the Runx3 À/À gastric epithelial cells, although some staining was observed in blood cells due to the intrinsic problem of using mouse monoclonal antibodies for immunohistochemistry of mouse tissues. With anti-mouse IgG as the secondary antibody, any host IgG within the tissues would be nonspecifically detected. The reactivity of the antibodies to the wildtype gastric tissues varied considerably (Figure 3c ). R3-1E10 and R3-3F12 yielded immunohistochemical (Figure 3b ). In the case of the chief cells, cytoplasmic Runx3 localization was immunodetected by R3-1E10 and R3-3F12 as we described for human gastric epithelium (Figure 3c;  Ito et al., 2005) . Significantly, however, neither R3-10C7 nor R3-8C9 reacted with the wild-type gastric epithelial cells (Figure 3a) . We tested the commercially available polyclonal anti-RUNX3 antibody (obtained from ACTIVE MOTIF) as it reportedly recognizes Runx3 in gastric epithelial cells (Wei et al., 2005; Peng et al., 2006) . This antibody mainly recognized a region À/À E.12.5 murine embryos. Immunohistochemical analysis was performed as described previously using 2 mg/ml of monoclonal antibodies or 1:1000-diluted G-poly. (b) Immunodetection of b-galactosidase in adult stomachs of Runx3 þ /À and WT mice. Immunohistochemical analysis using anti-bacterial b-galactosidase antibody (NE056/Bio; Nordic Immunological Laboratories) was performed as described previously (Chi et al., 2005) . (c) Runx3 in stomachs from adult WT and Runx3 À/À mice. Immunohistochemical analysis was performed as described above in (a). Insets show the enlargement of part of the figures. (d) Immunodetection of Runx3 in WT adult stomach using 1:300-diluted anti-RUNX3 polyclonal antibody from ACTIVE MOTIF (AM) and normal rabbit serum (control). Hematoxylin was employed for counterstaining in (c, d). Scale bars ¼ 100 mM.
Runx3 expression in gastrointestinal tract epithelium K Ito et al between residues 28 and 53 (Figure 2d ). Although we confirmed that this antibody recognizes Runx3 in the gastric epithelial cells, the signal was weaker than that obtained by R3-1E10 and R3-3F12 (Figures 3c and d) . As expected from results by Brenner et al. (2004) , G-poly reacted poorly with the wild-type gastric epithelium. Thus, R3-10C7 and G-poly, both recognizing the same region of RUNX3 (Figures 2c and d) , show weak specificity for Runx3 in gastric epithelial cells. Similarly, R3-8C9 also reacted with DRG neurons but not with gastric epithelial cells. Moreover, R3-1E10 shows the reverse pattern, namely, it reacts well with GIT epithelial cells but not with DRG neurons (Figures 3a and c) .
As shown in Figure 1c , R3-1E10, R3-3F12 and R3-10C7, through western blot analysis, detected Runx3 equally well in the mouse gastric epithelial cell extracts. However, when used as a probe during immunohistochemical analysis, R3-10C7 could hardly detect Runx3 in the GIT epithelium. These results clearly indicate that while Runx3 is present in the gastric epithelial cells, its detection during immunohistochemical analysis can be made only with certain anti-RUNX3 antibody clones.
All antibodies recognizing the RUNX3 N-terminal region (residues 1-234) reacted with gastric epithelial cells immunohistochemically, whereas those recognizing the C-terminal region (beyond residue 234) did not. This pattern suggests that the C-terminal region of Runx3 in GIT is specifically modified. Alternatively, the Cterminal region of Runx3 in GIT epithelium may be masked by a cellular protein that binds to Runx3 only in this tissue.
R3-3F12 and R3-1E10 recognize the same region of RUNX3 (Figure 2d ), yet they show different epitope specificities during immunohistochemistry. Therefore, we further dissected the region between 188 and 234. Both clones recognized the C-terminally truncated fragment up to Asp200 equally well. However, when Asp200 was removed, the reactivity of R3-3F12 was drastically reduced, whereas that of R3-1E10 was completely lost (Figure 2e ). We then replaced Asp200 with Ala [RUNX3(D200A)] or Lys [RUNX3(D200K)] and tested the reactivity of these two antibodies to these amino-acid substitutions. We found that R3-1E10 did not recognize RUNX3(D200A) nor RUNX3(D200K), whereas R3-3F12 weakly reacted with RUNX3(D200A) but not with RUNX3(D200K). These results suggest that epitope for R3-1E10 recognition is Asp200, whereas that for R3-3F12 spans Gly199-Asp200. These two monoclonal antibodies, therefore, display clearly different epitope specificities and this leads to differential reactivities to Runx3 in DRG neurons and GIT epithelium.
In conclusion, although GIT epithelial cells clearly express Runx3, G-poly cannot detect it in this tissue. Recently, we reported that RUNX3 is an attenuator against oncogenic Wnt signaling in human and mouse intestine. In the report, we provided evidence that tumor-suppressive effect of RUNX3 is epithelial cell autonomous . However, we do not exclude the possibility that non-epithelial cells such as T lymphocytes or mesenchymal cells would influence tumorigenicity of GIT epithelial cells.
